ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.54
1.35%
US Tech 100
19,613.20
1.97%
S&P 500
5,767.57
1.76%
US Dollar vs CAD
1.43122
-0.05%
Bitcoin
87,006.38
-0.58%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. aTyr Pharma Inc (ATYR)

  7. aTyr Pharma Inc (ATYR) News

ATYR

aTyr Pharma (ATYR)

aTyr Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATYR
DateTimeSourceHeadlineSymbolCompany
03/19/20253:15PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ATYRaTyr Pharma Inc
03/19/20253:11PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ATYRaTyr Pharma Inc
03/19/20253:08PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATYRaTyr Pharma Inc
03/17/20256:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATYRaTyr Pharma Inc
03/13/20254:19PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ATYRaTyr Pharma Inc
03/13/20253:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATYRaTyr Pharma Inc
03/13/20253:01PMGlobeNewswire Inc.aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate UpdateNASDAQ:ATYRaTyr Pharma Inc
03/12/20253:00PMGlobeNewswire Inc.aTyr Pharma Announces Publication Demonstrating Efzofitimod’s Immunomodulatory Activity in Science Translational MedicineNASDAQ:ATYRaTyr Pharma Inc
03/06/20253:02PMGlobeNewswire Inc.aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary SarcoidosisNASDAQ:ATYRaTyr Pharma Inc
03/04/20257:00AMGlobeNewswire Inc.aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 Financial ResultsNASDAQ:ATYRaTyr Pharma Inc
02/24/20257:00AMGlobeNewswire Inc.aTyr Pharma to Present at the Leerink Partners Global Healthcare ConferenceNASDAQ:ATYRaTyr Pharma Inc
02/04/20255:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATYRaTyr Pharma Inc
02/04/20255:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATYRaTyr Pharma Inc
01/29/20257:00AMGlobeNewswire Inc.aTyr Pharma to Present Three Posters for Efzofitimod at the American Thoracic Society (ATS) 2025 International ConferenceNASDAQ:ATYRaTyr Pharma Inc
01/10/20253:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATYRaTyr Pharma Inc
01/10/20253:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATYRaTyr Pharma Inc
12/23/20243:48PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ATYRaTyr Pharma Inc
12/23/20243:42PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATYRaTyr Pharma Inc
12/17/20247:00AMGlobeNewswire Inc.aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ATYRaTyr Pharma Inc
12/12/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATYRaTyr Pharma Inc
12/12/20243:12PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATYRaTyr Pharma Inc
12/12/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATYRaTyr Pharma Inc
12/12/20243:00PMGlobeNewswire Inc.aTyr Pharma Announces the Appointment of Eric Benevich to its Board of DirectorsNASDAQ:ATYRaTyr Pharma Inc
12/10/20247:00AMGlobeNewswire Inc.aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary SarcoidosisNASDAQ:ATYRaTyr Pharma Inc
12/09/20247:00AMGlobeNewswire Inc.aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on FibrosisNASDAQ:ATYRaTyr Pharma Inc
11/15/20247:00AMGlobeNewswire Inc.aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on FibrosisNASDAQ:ATYRaTyr Pharma Inc
11/14/20245:51PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ATYRaTyr Pharma Inc
11/07/20243:07PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATYRaTyr Pharma Inc
11/07/20243:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATYRaTyr Pharma Inc
11/07/20243:01PMGlobeNewswire Inc.aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate UpdateNASDAQ:ATYRaTyr Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:ATYR

Your Recent History

COIN
VENEUR
VeChain
NASDAQ
FFHVX
Gqg Partners Internation...
NYSE
TXNM
TXNM Energy
LSE
BNKS
Ish Sp Us Bnks
UNSW3
SKLETH
SKALE
COIN
FNSAUSD
Finschia
NASDAQ
RUN
Sunrun
LSE
BR71
Bank Mont.29
NASDAQ
RMBL
RumbleOn
NASDAQ
FETWX
Bmo Us Dollar Monthly In...
NASDAQ
BTMD
Biote
COIN
GCCGBP
Gric Coin
COIN
LOLTUSD
LOLTOKEN
TSX
H
Hydro One
COIN
TNSUSD
Transcodium
NASDAQ
ZIONP
Zions Bancorporation NA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads